Copyright Reports & Markets. All rights reserved.

Global and United States GP Vaccination Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 GP Vaccination Product Introduction
    • 1.2 Global GP Vaccination Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global GP Vaccination Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global GP Vaccination Sales in Volume for the Year 2017-2028
    • 1.3 United States GP Vaccination Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States GP Vaccination Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States GP Vaccination Sales in Volume for the Year 2017-2028
    • 1.4 GP Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States GP Vaccination in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of GP Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 GP Vaccination Market Dynamics
      • 1.5.1 GP Vaccination Industry Trends
      • 1.5.2 GP Vaccination Market Drivers
      • 1.5.3 GP Vaccination Market Challenges
      • 1.5.4 GP Vaccination Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 GP Vaccination Market Segment by Type
      • 2.1.1 DNA
      • 2.1.2 Non-replicating Viral Vector
      • 2.1.3 Protein Subunit
      • 2.1.4 RNA
      • 2.1.5 Others
    • 2.2 Global GP Vaccination Market Size by Type
      • 2.2.1 Global GP Vaccination Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global GP Vaccination Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global GP Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States GP Vaccination Market Size by Type
      • 2.3.1 United States GP Vaccination Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States GP Vaccination Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States GP Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 GP Vaccination Market Segment by Application
      • 3.1.1 Adults
      • 3.1.2 Children
    • 3.2 Global GP Vaccination Market Size by Application
      • 3.2.1 Global GP Vaccination Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global GP Vaccination Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global GP Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States GP Vaccination Market Size by Application
      • 3.3.1 United States GP Vaccination Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States GP Vaccination Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States GP Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global GP Vaccination Competitor Landscape by Company

    • 4.1 Global GP Vaccination Market Size by Company
      • 4.1.1 Top Global GP Vaccination Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global GP Vaccination Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global GP Vaccination Sales by Manufacturer (2017-2022)
      • 4.1.4 Global GP Vaccination Price by Manufacturer (2017-2022)
    • 4.2 Global GP Vaccination Concentration Ratio (CR)
      • 4.2.1 GP Vaccination Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of GP Vaccination in 2021
      • 4.2.3 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global GP Vaccination Manufacturing Base Distribution, Product Type
      • 4.3.1 Global GP Vaccination Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers GP Vaccination Product Type
      • 4.3.3 Date of International Manufacturers Enter into GP Vaccination Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States GP Vaccination Market Size by Company
      • 4.5.1 Top GP Vaccination Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States GP Vaccination Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States GP Vaccination Sales by Players (2020, 2021 & 2022)

    5 Global GP Vaccination Market Size by Region

    • 5.1 Global GP Vaccination Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global GP Vaccination Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global GP Vaccination Sales in Volume by Region: 2017-2022
      • 5.2.2 Global GP Vaccination Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global GP Vaccination Market Size in Value by Region (2017-2028)
      • 5.3.1 Global GP Vaccination Sales in Value by Region: 2017-2022
      • 5.3.2 Global GP Vaccination Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America GP Vaccination Market Size YoY Growth 2017-2028
      • 6.1.2 North America GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific GP Vaccination Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific GP Vaccination Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe GP Vaccination Market Size YoY Growth 2017-2028
      • 6.3.2 Europe GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America GP Vaccination Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa GP Vaccination Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa GP Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Moderna
      • 7.1.1 Moderna Corporation Information
      • 7.1.2 Moderna Description and Business Overview
      • 7.1.3 Moderna GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Moderna GP Vaccination Products Offered
      • 7.1.5 Moderna Recent Development
    • 7.2 CanSino Biologicals
      • 7.2.1 CanSino Biologicals Corporation Information
      • 7.2.2 CanSino Biologicals Description and Business Overview
      • 7.2.3 CanSino Biologicals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 CanSino Biologicals GP Vaccination Products Offered
      • 7.2.5 CanSino Biologicals Recent Development
    • 7.3 Inovio Pharmaceuticals
      • 7.3.1 Inovio Pharmaceuticals Corporation Information
      • 7.3.2 Inovio Pharmaceuticals Description and Business Overview
      • 7.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Inovio Pharmaceuticals GP Vaccination Products Offered
      • 7.3.5 Inovio Pharmaceuticals Recent Development
    • 7.4 Shenzhen Geno-Immune Medical Institute
      • 7.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
      • 7.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
      • 7.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Products Offered
      • 7.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
    • 7.5 GlaxoSmithKine
      • 7.5.1 GlaxoSmithKine Corporation Information
      • 7.5.2 GlaxoSmithKine Description and Business Overview
      • 7.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 GlaxoSmithKine GP Vaccination Products Offered
      • 7.5.5 GlaxoSmithKine Recent Development
    • 7.6 Pfizer
      • 7.6.1 Pfizer Corporation Information
      • 7.6.2 Pfizer Description and Business Overview
      • 7.6.3 Pfizer GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Pfizer GP Vaccination Products Offered
      • 7.6.5 Pfizer Recent Development
    • 7.7 Johnson＆Johnson
      • 7.7.1 Johnson＆Johnson Corporation Information
      • 7.7.2 Johnson＆Johnson Description and Business Overview
      • 7.7.3 Johnson＆Johnson GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Johnson＆Johnson GP Vaccination Products Offered
      • 7.7.5 Johnson＆Johnson Recent Development
    • 7.8 Heat Biologics
      • 7.8.1 Heat Biologics Corporation Information
      • 7.8.2 Heat Biologics Description and Business Overview
      • 7.8.3 Heat Biologics GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Heat Biologics GP Vaccination Products Offered
      • 7.8.5 Heat Biologics Recent Development
    • 7.9 Sanofi
      • 7.9.1 Sanofi Corporation Information
      • 7.9.2 Sanofi Description and Business Overview
      • 7.9.3 Sanofi GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Sanofi GP Vaccination Products Offered
      • 7.9.5 Sanofi Recent Development
    • 7.10 Takis Biotech
      • 7.10.1 Takis Biotech Corporation Information
      • 7.10.2 Takis Biotech Description and Business Overview
      • 7.10.3 Takis Biotech GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Takis Biotech GP Vaccination Products Offered
      • 7.10.5 Takis Biotech Recent Development
    • 7.11 Zydus Cadila
      • 7.11.1 Zydus Cadila Corporation Information
      • 7.11.2 Zydus Cadila Description and Business Overview
      • 7.11.3 Zydus Cadila GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Zydus Cadila GP Vaccination Products Offered
      • 7.11.5 Zydus Cadila Recent Development
    • 7.12 Codagenix
      • 7.12.1 Codagenix Corporation Information
      • 7.12.2 Codagenix Description and Business Overview
      • 7.12.3 Codagenix GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Codagenix Products Offered
      • 7.12.5 Codagenix Recent Development
    • 7.13 GeoVax
      • 7.13.1 GeoVax Corporation Information
      • 7.13.2 GeoVax Description and Business Overview
      • 7.13.3 GeoVax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 GeoVax Products Offered
      • 7.13.5 GeoVax Recent Development
    • 7.14 Bravovax
      • 7.14.1 Bravovax Corporation Information
      • 7.14.2 Bravovax Description and Business Overview
      • 7.14.3 Bravovax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 Bravovax Products Offered
      • 7.14.5 Bravovax Recent Development
    • 7.15 Altimmune
      • 7.15.1 Altimmune Corporation Information
      • 7.15.2 Altimmune Description and Business Overview
      • 7.15.3 Altimmune GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Altimmune Products Offered
      • 7.15.5 Altimmune Recent Development
    • 7.16 Vaxart
      • 7.16.1 Vaxart Corporation Information
      • 7.16.2 Vaxart Description and Business Overview
      • 7.16.3 Vaxart GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 Vaxart Products Offered
      • 7.16.5 Vaxart Recent Development
    • 7.17 Clover Biopharmaceuticals
      • 7.17.1 Clover Biopharmaceuticals Corporation Information
      • 7.17.2 Clover Biopharmaceuticals Description and Business Overview
      • 7.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Clover Biopharmaceuticals Products Offered
      • 7.17.5 Clover Biopharmaceuticals Recent Development
    • 7.18 ImmunoPrecise
      • 7.18.1 ImmunoPrecise Corporation Information
      • 7.18.2 ImmunoPrecise Description and Business Overview
      • 7.18.3 ImmunoPrecise GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
      • 7.18.4 ImmunoPrecise Products Offered
      • 7.18.5 ImmunoPrecise Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 GP Vaccination Industry Chain Analysis
    • 8.2 GP Vaccination Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 GP Vaccination Distributors
    • 8.3 GP Vaccination Production Mode & Process
    • 8.4 GP Vaccination Sales and Marketing
      • 8.4.1 GP Vaccination Sales Channels
      • 8.4.2 GP Vaccination Distributors
    • 8.5 GP Vaccination Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States GP Vaccination Market
      This report focuses on global and United States GP Vaccination market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global GP Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, DNA accounting for % of the GP Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Adults was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the GP Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global GP Vaccination Scope and Market Size
      GP Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global GP Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the GP Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the GP Vaccination market is segmented into
      DNA
      Non-replicating Viral Vector
      Protein Subunit
      RNA
      Others
      Segment by Application, the GP Vaccination market is segmented into
      Adults
      Children
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and GP Vaccination Market Share Analysis
      GP Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in GP Vaccination business, the date to enter into the GP Vaccination market, GP Vaccination product introduction, recent developments, etc.
      The major vendors covered:
      Moderna
      CanSino Biologicals
      Inovio Pharmaceuticals
      Shenzhen Geno-Immune Medical Institute
      GlaxoSmithKine
      Pfizer
      Johnson＆Johnson
      Heat Biologics
      Sanofi
      Takis Biotech
      Zydus Cadila
      Codagenix
      GeoVax
      Bravovax
      Altimmune
      Vaxart
      Clover Biopharmaceuticals
      ImmunoPrecise
      Buy now